Search research articles
Contact Us
Filters
Showing results (641-650 of 657) with videos related to
Page
of 66
Sort By:
European Radiology
|
June 27, 2023
Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study
Zhi-Cheng Jin, Bin-Yan Zhong, Jian-Jian Chen, et al.
European Journal of Medicinal Chemistry
|
October 15, 2018
Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia
Xuesong Liu, Beilei Wang, Cheng Chen, et al.
Haematologica
|
November 27, 2025
Cell-free BRAF-V600E levels predict progression-free survival in children with Langerhans cell histiocytosis treated with dabrafenib and maintenance chemotherapy
Lei Cui, Dong Wang, Yun-Ze Zhao, et al.
Nature
|
September 6, 2019
Fast inflows as the adjacent fuel of supermassive black hole accretion disks in quasars
Hongyan Zhou, Xiheng Shi, Weimin Yuan, et al.
Journal of Medicinal Chemistry
|
September 29, 2017
Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutants in FLT3-ITD Positive AML
Aoli Wang, Xixiang Li, Cheng Chen, et al.
Plos Medicine
|
November 23, 2005
CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD
Kristinn P Magnusson, Shan Duan, Haraldur Sigurdsson, et al.
Cell Stem Cell
|
September 4, 2024
Human vascularized macrophage-islet organoids to model immune-mediated pancreatic β cell pyroptosis upon viral infection
Liuliu Yang, Yuling Han, Tuo Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
Human Vascularized Macrophage-Islet Organoids to Model Immune-Mediated Pancreatic β cell Pyroptosis upon Viral Infection
Liuliu Yang, Yuling Han, Tuo Zhang, et al.
American Journal of Translational Research
|
May 5, 2017
Crizotinib synergizes with cisplatin in preclinical models of ovarian cancer
Xiao-Xiu Huang, Feng-Feng Xie, Li-Jiao Hou, et al.
Molecular Medicine (Cambridge, Mass.)
|
February 13, 2021
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma
Ying Zhu, Kun-Bin Ke, Zhong-Kun Xia, et al.
Page
of 66
Search research articles
Search
Showing results (641-650 of 657) with videos related to
Sort By:
Page
of 66
European Radiology
|
June 27, 2023
Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study
Zhi-Cheng Jin, Bin-Yan Zhong, Jian-Jian Chen, et al.
European Journal of Medicinal Chemistry
|
October 15, 2018
Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia
Xuesong Liu, Beilei Wang, Cheng Chen, et al.
Haematologica
|
November 27, 2025
Cell-free BRAF-V600E levels predict progression-free survival in children with Langerhans cell histiocytosis treated with dabrafenib and maintenance chemotherapy
Lei Cui, Dong Wang, Yun-Ze Zhao, et al.
Nature
|
September 6, 2019
Fast inflows as the adjacent fuel of supermassive black hole accretion disks in quasars
Hongyan Zhou, Xiheng Shi, Weimin Yuan, et al.
Journal of Medicinal Chemistry
|
September 29, 2017
Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutants in FLT3-ITD Positive AML
Aoli Wang, Xixiang Li, Cheng Chen, et al.
Plos Medicine
|
November 23, 2005
CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD
Kristinn P Magnusson, Shan Duan, Haraldur Sigurdsson, et al.
Cell Stem Cell
|
September 4, 2024
Human vascularized macrophage-islet organoids to model immune-mediated pancreatic β cell pyroptosis upon viral infection
Liuliu Yang, Yuling Han, Tuo Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
Human Vascularized Macrophage-Islet Organoids to Model Immune-Mediated Pancreatic β cell Pyroptosis upon Viral Infection
Liuliu Yang, Yuling Han, Tuo Zhang, et al.
American Journal of Translational Research
|
May 5, 2017
Crizotinib synergizes with cisplatin in preclinical models of ovarian cancer
Xiao-Xiu Huang, Feng-Feng Xie, Li-Jiao Hou, et al.
Molecular Medicine (Cambridge, Mass.)
|
February 13, 2021
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma
Ying Zhu, Kun-Bin Ke, Zhong-Kun Xia, et al.
Page
of 66